Loading clinical trials...
Loading clinical trials...
A Mixed-Methods Pilot Study of a Trauma-Sensitive Mindfulness and Compassion Intervention
This mixed-methods pilot study aim to assess the changes in symptoms of post-traumatic stress disorder (PTSD), complex post-traumatic stress disorder (CPTSD), dissociative symptoms, self-critique, and self-compassion following participation in a 16-week trauma-sensitive mindfulness and compassion (TMC) intervention. Adverse experiences of participation are also explored explicitly.
Seventeen clients most female with severe childhood abuse and PTSD and CPTSD participated in the TMC intervention. A mixed-methods design was used. All clients completed questionnaires before (pre) and after (post) the intervention to gain information on symptom change, self-critique, and self-compassion. Second, a qualitative interview addressing clients' experiences of participation, including an explicit focus on adverse experiences, was conducted.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
Modum Bad
Vikersund, Norway
Start Date
January 1, 2019
Primary Completion Date
January 1, 2020
Completion Date
March 1, 2023
Last Updated
August 21, 2023
17
ACTUAL participants
TMC Treatment Approach
OTHER
Lead Sponsor
Modum Bad
NCT06516874
NCT06549777
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions